The Molecular Biology Core is a critical component of the NIDA P30 Center at Temple University. The Molecular Core offers services to investigators that involve either short- or long- term use of molecular techniques. This Core provides three types of services. First, the Core supports the design and construction of molecular constructs for the expression of genes of interest. This will include, for example, the expression either in vitro or in vivo of opioid or cannabinoid receptors. These molecular constructs will permit a variety of studies of interest to collaborating investigators including the analysis of receptor-mediated signaling processes and the analysis of the cellular trafficking of receptors (or other genes of interest). Second, the Molecular Biology Core will provide gene expression analysis both in vitro and in vivo. The Core provides highly quantitative analysis of mRNA and miRNA expression using RT-PCR, northern blot analysis, RNase protection analysis, and new to this renewal application, the novel FISH flow (PrimeFlow) analysis. The Core also offers comprehensive transcription factor function analyses. Third, the Core provides genotyping services for the Animal Core and to other investigators breeding mutant animals. Services are provided for investigators who span a variety of disciplines and work is carried out in direct collaboration with the investigator. The Molecular Biology Core is particularly interested in continuing efforts to promote the use of molecular techniques to study the role of drugs of abuse in the host-parasite interaction with HIV. The Core has been highly successful in engaging NIH-funded investigators from many disciplines in collaborative research projects that have advanced the understanding of the actions of drugs of abuse and their interplay with the immune system and with HIV. By combining the expertise of investigators with diverse interests, new perspectives and potentially novel investigations can be developed.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Temple University
United States
Zip Code
Ward, Sara Jane; Castelli, Francesca; Reichenbach, Zachary W et al. (2018) Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia. Life Sci 195:1-5
Liu, Jeffrey J; Sharma, Kirti; Zangrandi, Luca et al. (2018) In vivo brain GPCR signaling elucidated by phosphoproteomics. Science 360:
Oliver, Chicora F; Simmons, Steven J; Nayak, Sunil U et al. (2018) Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats. Drug Alcohol Depend 186:75-79
Zewde, Ashenafi Mebratu; Yu, Frances; Nayak, Sunil et al. (2018) PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects. J Neurosci Methods 293:284-288
Rom, Slava; Zuluaga-Ramirez, Viviana; Reichenbach, Nancy L et al. (2018) Secoisolariciresinol diglucoside is a blood-brain barrier protective and anti-inflammatory agent: implications for neuroinflammation. J Neuroinflammation 15:25
Ramirez, Servio H; Andrews, Allison M; Paul, Debayon et al. (2018) Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers. Fluids Barriers CNS 15:19
Brailoiu, Eugen; Barlow, Christine L; Ramirez, Servio H et al. (2018) Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells. Neuroscience 377:105-113
Barbe, Mary F; Massicotte, Vicky S; Assari, Soroush et al. (2018) Prolonged high force high repetition pulling induces osteocyte apoptosis and trabecular bone loss in distal radius, while low force high repetition pulling induces bone anabolism. Bone 110:267-283
Gentile, Taylor A; Simmons, Steven J; Barker, David J et al. (2018) Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine. Addict Biol 23:247-255
Hicks, Callum; Huang, Peng; Ramos, Linnet et al. (2018) Dopamine D1-Like Receptor Agonist and D2-Like Receptor Antagonist (-)-Stepholidine Reduces Reinstatement of Drug-Seeking Behavior for 3,4-Methylenedioxypyrovalerone (MDPV) in Rats. ACS Chem Neurosci 9:1327-1337

Showing the most recent 10 out of 343 publications